Administration of plasmacytoid dendritic cell-stimulative lactic acid bacteria is effective against dengue virus infection in mice

Suzuki,Hiroaki; Tsuji,Ryohei; Sugamata,Miho; Yamamoto,Naoki; Yamamoto,Norio; Kanauchi,Osamu

doi:10.3892/ijmm.2018.3955

Administration of plasmacytoid dendritic cell-stimulative lactic acid bacteria is effective against dengue virus infection in mice

Authors:
- Hiroaki Suzuki
- Ryohei Tsuji
- Miho Sugamata
- Naoki Yamamoto
- Norio Yamamoto
- Osamu Kanauchi
View Affiliations

Affiliations: Research Laboratories for Health Science and Food Technologies, Kirin Company, Ltd., Yokohama‑shi, Kanagawa 236‑0004, Japan, National Institute of Infectious Diseases, Tokyo 162‑8640, Japan, Department of Infection Control Science, Graduate School of Medicine, Juntendo University, Tokyo 113‑8421, Japan
Published online on: October 24, 2018 https://doi.org/10.3892/ijmm.2018.3955
Pages: 426-434

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dengue virus (DENV), a mosquito‑borne flavivirus, causes an acute febrile illness that is a major public health problem in the tropics and subtropics globally. However, methods to prevent or treat DENV infection have not been well established. It was previously demonstrated that Lactococcus lactis strain plasma (LC‑plasma) has the ability to stimulate plasmacytoid dendritic cells (pDCs). As pDCs are key immune cells that control viral infection by producing large amounts of type I interferons (IFN), the present study evaluated the effect of LC‑plasma on DENV infection using a mouse infectious DENV strain. Mice were divided into two groups and the test group was orally administered LC‑plasma for two weeks. Two weeks following administration, the mice were infected with DENV and the relative viral titers and the expression of the inflammatory genes in DENV‑infected tissue were measured using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR). The relative viral titers were notably lower in the DENV‑infected tissues compared with the control group when LC‑plasma was orally administered prior to DENV infection. Furthermore, the expression of the inflammatory genes associated with DENV infection was also reduced by LC‑plasma administration. To investigate how LC‑plasma administration controls DENV infection, the present study examined anti‑viral gene expression, which is critical for the viral clearance induced by type I IFN. Two weeks subsequent to the administration of LC‑plasma, the expression of anti‑viral gene was measured using RT‑qPCR. Oral intake of LC‑plasma enhanced anti‑viral gene expression in DENV‑infected spleen tissue. To clarify the detailed mechanism, in vitro co‑culture studies using bone‑marrow derived DC (BMDC) were performed. BMDC were stimulated with LC‑plasma in combination with anti‑IFN‑α/β antibody and the expression of anti‑viral genes was measured. In vitro studies revealed that the effect of LC‑plasma on anti‑viral genes was dependent on type I IFN. Based on these results, LC‑plasma may be effective against DENV infection by stimulating pDCs, which results in the increased production of anti‑viral factors.

View Figures

View References

1	Diamond MS and Pierson TC: Molecular Insight into dengue virus pathogenesis and its implications for disease control. Cell. 162:488–492. 2015. View Article : Google Scholar : PubMed/NCBI
2	Holmes EC and Burch SS: The causes and consequences of genetic variation in dengue virus. Trends Microbiol. 8:74–77. 2000. View Article : Google Scholar : PubMed/NCBI
3	Halstead SB: Dengue. Lancet. 370:1644–1652. 2007. View Article : Google Scholar : PubMed/NCBI
4	Gubler DJ: Dengue/dengue haemorrhagic fever: History and current status. Novartis Found Symp. 277:3–16. 16–22. 71–73. 251–253. 2006.
5	Srikiatkhachorn A, Mathew A and Rothman AL: Immune- mediated cytokine storm and its role in severe dengue. Semin Immunopath. 39:563–574. 2017. View Article : Google Scholar
6	Guzman MG and Kouri G: Dengue: An update. Lancet Infect Dis. 2:33–42. 2002. View Article : Google Scholar : PubMed/NCBI
7	Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, Viramitrachai W, Ratanachu-eke S, Kiatpolpoj S, Innis BL, et al: Early clinical and laboratory indicators of acute dengue illness. J Infect Dis. 176:313–321. 1997. View Article : Google Scholar : PubMed/NCBI
8	Fagundes CT, Costa VV, Cisalpino D, Souza DG and Teixeira MM: Therapeutic opportunities in dengue infection. Drug Devel Res. 72:480–500. 2011. View Article : Google Scholar
9	Perry AK, Chen G, Zheng D, Tang H and Cheng G: The host type I interferon response to viral and bacterial infections. Cell Res. 15:407–422. 2005. View Article : Google Scholar : PubMed/NCBI
10	Stetson DB and Medzhitov R: Type I interferons in host defense. Immunity. 25:373–381. 2006. View Article : Google Scholar : PubMed/NCBI
11	Fleming SB: Viral inhibition of the IFN-induced JAK/STAT signalling pathway: Development of live attenuated vaccines by mutation of viral-encoded IFN-antagonists. Vaccines. 4:pii: E232016. View Article : Google Scholar
12	Schoggins JW, Dorner M, Feulner M, Imanaka N, Murphy MY, Ploss A and Rice CM: Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci USA. 109:14610–14615. 2012. View Article : Google Scholar : PubMed/NCBI
13	Zellweger RM, Prestwood TR and Shresta S: Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe. 7:128–139. 2010. View Article : Google Scholar : PubMed/NCBI
14	Zust R, Toh YX, Valdes I, Cerny D, Heinrich J, Hermida L, Marcos E, Guillén G, Kalinke U, Shi PY, et al: Type I interferon signals in macrophages and dendritic cells control dengue virus infection: Implications for a new mouse model to test dengue vaccines. J Virol. 88:7276–7285. 2014. View Article : Google Scholar : PubMed/NCBI
15	Sarathy VV, White M, Li L, Gorder SR, Pyles RB, Campbell GA, Milligan GN, Bourne N and Barrett AD: A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. J Virol. 89:1254–1266. 2015. View Article : Google Scholar :
16	Diamond MS and Harris E: Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology. 289:297–311. 2001. View Article : Google Scholar : PubMed/NCBI
17	Helbig KJ, Carr JM, Calvert JK, Wati S, Clarke JN, Eyre NS, Narayana SK, Fiches GN, McCartney EM and Beard MR: Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Negl Trop Dis. 7:e21782013. View Article : Google Scholar : PubMed/NCBI
18	Hishiki T, Han Q, Arimoto K, Shimotohno K, Igarashi T, Vasudevan SG, Suzuki Y and Yamamoto N: Interferon-mediated ISG15 conjugation restricts dengue virus 2 replication. Biochem Biophys Res Commun. 448:95–100. 2014. View Article : Google Scholar : PubMed/NCBI
19	Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S and Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood. Science. 284:1835–1837. 1999. View Article : Google Scholar : PubMed/NCBI
20	Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A and Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med. 5:919–923. 1999. View Article : Google Scholar : PubMed/NCBI
21	Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A and Flavell RA: Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci USA. 101:5598–5603. 2004. View Article : Google Scholar : PubMed/NCBI
22	Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, et al: A Toll-like receptor recognizes bacterial DNA. Nature. 408:740–745. 2000. View Article : Google Scholar : PubMed/NCBI
23	Bauer S, Kirschning CJ, Häcker H, Redecke V, Hausmann S, Akira S, Wagner H and Lipford GB: Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA. 98:9237–9242. 2001. View Article : Google Scholar : PubMed/NCBI
24	Gilliet M, Cao W and Liu YJ: Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 8:594–606. 2008. View Article : Google Scholar : PubMed/NCBI
25	Perdigon G, Fuller R and Raya R: Lactic acid bacteria and their effect on the immune system. Current Issues Intest Microbiol. 2:27–42. 2001.
26	Parcina M, Wendt C, Goetz F, Zawatzky R, Zähringer U, Heeg K and Bekeredjian-Ding I: Staphylococcus aureus-induced plasmacytoid dendritic cell activation is based on an IgG-mediated memory response. J Immunol. 181:3823–3833. 2008. View Article : Google Scholar : PubMed/NCBI
27	Piccioli D, Sammicheli C, Tavarini S, Nuti S, Frigimelica E, Manetti AG, Nuccitelli A, Aprea S, Valentini S, Borgogni E, et al: Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation. Blood. 113:4232–4239. 2009. View Article : Google Scholar : PubMed/NCBI
28	Jounai K, Ikado K, Sugimura T, Ano Y, Braun J and Fujiwara D: Spherical lactic acid bacteria activate plasmacytoid dendritic cells immunomodulatory function via TLR9-dependent crosstalk with myeloid dendritic cells. PLoS One. 7:e325882012. View Article : Google Scholar : PubMed/NCBI
29	Jounai K, Sugimura T, Ohshio K and Fujiwara D: Oral administration of Lactococcus lactis subsp lactis JCM5805 enhances lung immune response resulting in protection from murine para-influenza virus infection. PLoS One. 10:e01190552015. View Article : Google Scholar
30	Jounai K, Sugimura T, Morita Y, Ohshio K and Fujiwara D: Administration of Lactococcus lactis strain Plasma induces maturation of plasmacytoid dendritic cells and protection from rotavirus infection in suckling mice. Int Immunopharmacol. 56:205–211. 2018. View Article : Google Scholar : PubMed/NCBI
31	Castillo Ramirez JA and Urcuqui-Inchima S: Dengue virus control of type I IFN responses: A history of manipulation and control. J Interferon Cytokine Res. 35:421–430. 2015. View Article : Google Scholar : PubMed/NCBI
32	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔ^C^T method. Methods. 25:402–408. 2001. View Article : Google Scholar
33	St John AL, Rathore AP, Raghavan B, Ng ML and Abraham SN: Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife. 2:e004812013. View Article : Google Scholar : PubMed/NCBI
34	da Costa VG, Marques-Silva AC and Moreli ML: A meta-analysis of the diagnostic accuracy of two commercial NS1 antigen ELISA tests for early dengue virus detection. PLoS One. 9:e946552014. View Article : Google Scholar : PubMed/NCBI
35	Brawand P, Fitzpatrick DR, Greenfield BW, Brasel K, Maliszewski CR and De Smedt T: Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J Immunol. 169:6711–6719. 2002. View Article : Google Scholar : PubMed/NCBI
36	Raut CG, Deolankar RP, Kolhapure RM and Goverdhan MK: Susceptibility of laboratory-bred rodents to the experimental infection with dengue virus type 2. Acta Virol. 40:143–146. 1996.PubMed/NCBI
37	Johnson AJ and Roehrig JT: New mouse model for dengue virus vaccine testing. J Virol. 73:783–786. 1999.
38	Orozco S, Schmid MA, Parameswaran P, Lachica R, Henn MR, Beatty R and Harris E: Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor. J Gen Virol. 93:2152–2157. 2012. View Article : Google Scholar : PubMed/NCBI
39	Zellweger RM and Shresta S: Mouse models to study dengue virus immunology and pathogenesis. Front Immunol. 5:1512014. View Article : Google Scholar : PubMed/NCBI
40	Syenina A, Jagaraj CJ, Aman SA, Sridharan A and St John AL: Dengue vascular leakage is augmented by mast cell degranulation mediated by immunoglobulin Fcγ receptors. Elife. 4: View Article : Google Scholar : 2015.
41	Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 11:480–496. 1998. View Article : Google Scholar : PubMed/NCBI
42	Green S and Rothman A: Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr Opin Infect Dis. 19:429–436. 2006. View Article : Google Scholar : PubMed/NCBI
43	Srikiatkhachorn A: Plasma leakage in dengue haemorrhagic fever. Thromb Haemost. 102:1042–1049. 2009. View Article : Google Scholar : PubMed/NCBI
44	Chaturvedi UC, Agarwal R, Elbishbishi EA and Mustafa AS: Cytokine cascade in dengue hemorrhagic fever: Implications for pathogenesis. FEMS Immunol Med Microbiol. 28:183–188. 2000. View Article : Google Scholar : PubMed/NCBI
45	Verhelst J, Hulpiau P and Saelens X: Mx proteins: Antiviral gatekeepers that restrain the uninvited. Microbiol Mol Biol Rev. 77:551–566. 2013. View Article : Google Scholar : PubMed/NCBI
46	Fitzgerald KA: The interferon inducible gene: Viperin. J Interferon Cytokine Res. 31:131–135. 2011. View Article : Google Scholar :
47	Zhao C, Collins MN, Hsiang TY and Krug RM: Interferon- induced ISG15 pathway: An ongoing virus-host battle. Trends Microbiol. 21:181–186. 2013. View Article : Google Scholar : PubMed/NCBI
48	Elkhateeb E, Tag-El-Din-Hassan HT, Sasaki N, Torigoe D, Morimatsu M and Agui T: The role of mouse 2′,5′-oligoadenylate synthetase 1 paralogs. Infect Genet Evol. 45:393–401. 2016. View Article : Google Scholar : PubMed/NCBI
49	Takeda S, Takeshita M, Kikuchi Y, Dashnyam B, Kawahara S, Yoshida H, Watanabe W, Muguruma M and Kurokawa M: Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice: Alleviation of influenza infection by its immunomodulatory activity through intestinal immunity. Int Immunopharmacol. 11:1976–1983. 2011. View Article : Google Scholar : PubMed/NCBI
50	Fujiwara D, Inoue S, Wakabayashi H and Fujii T: The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol. 135:205–215. 2004. View Article : Google Scholar : PubMed/NCBI
51	Wakabayashi H, Nariai C, Takemura F, Nakao W and Fujiwara D: Dietary supplementation with lactic acid bacteria attenuates the development of atopic-dermatitis-like skin lesions in NC/Nga mice in a strain-dependent manner. Int Arch Allergy Immunol. 145:141–151. 2008. View Article : Google Scholar